Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Bristol Myers Squibb has declared a quarterly dividend of $0.62 per common share, yielding 4.16%, payable on May 1, 2025. The ...

Bristol Myers Squibb. “This is the first and only Phase 3 study of a neoadjuvant-only immuno-oncology therapy to show a statistically significant benefit in patients with resectable NSCLC.” ...

Sandra Leung, one of the longest-serving legal chiefs in the pharmaceutical industry, plans to retire from Bristol Myers Squibb in 2025 ... roles in oncology and commercial legal and compliance.

Bristol Myers Squibb has bolstered its case for Opdivo to be used as a preoperative treatment for non-small cell lung cancer (NSCLC) as it has delivered an overall survival (OS) edge when added to ...

A self-declared "serial killer" who likened himself to the fictional Halloween character Michael Myers has been sentenced to a further 159 years in jail. Joshua Dotson, 24, pleaded guilty to the ...

Already imprisoned for 100 years, the self-proclaimed "serial killer" who dubbed himself after Halloween slasher Michael Myers on the stand is now facing more than 150 additional years behind bars ...

Bristol Myers (BMY) Squibb announced new five-year results from the POETYK PSO long-term extension, LTE, trial of Sotyktu treatment in adult patients with moderate-to-severe plaque psoriasis.

Mike Myers returned to “Saturday Night Live” in the most classic way during the show’s 50th-anniversary special on Sunday. The comedian reprised his role as Linda Richman. Myers popularized ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best drug stocks to buy now. Large American pharmaceutical companies are showing ...